Explainers
Short, source-supported answers to high-value questions about BIOT and its science.
3 published
Explainers·
What is BIOT? INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC., explained
BIOT is the Nasdaq ticker symbol of INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC., a holding company incorporated in the Cayman Islands whose ordinary shares began trading on The Nasdaq Stock Market on 24 July 2026. Its operating businesses originate in Japan and span research and development, sourcing, manufacturing, regenerative medicine-related technologies, cosmetics, wellness and consumer brands. It is a separate legal entity from its operating subsidiaries, including INSTINCT BROTHERS.
ReadExplainers·
What are exosomes? A plain-language explainer
Exosomes are small extracellular vesicles — membrane-bound particles roughly 30–150 nanometres across — that cells release to carry proteins, lipids and nucleic acids to other cells. Researchers study them as a mechanism of cell-to-cell signalling and as a possible delivery vehicle. The international standard for reporting such research is MISEV, published by the International Society for Extracellular Vesicles. In the United States, exosome products are not approved by the FDA for treating any condition, and the FDA has issued consumer warnings on unapproved exosome and stem cell products.
ReadExplainers·
What does vertical integration mean in biotechnology?
Vertical integration means a single group owns consecutive stages of its value chain rather than buying them from third parties. In biotechnology that typically means research, materials sourcing, manufacturing, brand development and distribution sitting inside one corporate structure. The practical effect is control: one quality standard, traceability from material to finished lot, and faster iteration between research and product. It does not, by itself, make any product more effective, and it does not replace regulatory approval.
Read